|
Video: What is a Stock Split?
|
|
MyMD Pharmaceuticals is a clinical stage pharmaceutical company. Co. is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MYMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease and is being developed to treat age-related illnesses. Supera-CBD is a synthetic analog of cannabidiol being developed to treat various conditions, including epilepsy, pain and anxiety/depression, through its effects on the CB2 receptor, opioid receptors and monoamine oxidase enzyme type B. According to our MYMD split history records, MyMD Pharmaceuticals has had 2 splits. | |
|
MyMD Pharmaceuticals (MYMD) has 2 splits in our MYMD split history database. The first split for MYMD took place on April 19, 2021. This was a 1 for 2 reverse split, meaning for each 2 shares of MYMD owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 500 share position following the split. MYMD's second split took place on February 15, 2024. This was a 1 for 30 reverse split, meaning for each 30 shares of MYMD owned pre-split, the shareholder now owned 1 share. For example, a 500 share position pre-split, became a 16.6666666666667 share position following the split.
When a company such as MyMD Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the MYMD split history from start to finish, an original position size of 1000 shares would have turned into 16.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into MyMD Pharmaceuticals shares, starting with a $10,000 purchase of MYMD, presented on a split-history-adjusted basis factoring in the complete MYMD split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$226.20 |
|
End price/share: |
$2.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.87% |
|
Average Annual Total Return: |
-36.11% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$113.19 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
04/19/2021 | 1 for 2 | 02/15/2024 | 1 for 30 |
|
|